BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16479856)

  • 1. Imaging modalities in head and neck oncology: a surgical perspective.
    McGurk M; Jones J; Brown J
    Ann R Australas Coll Dent Surg; 2004 Oct; 17():51-6. PubMed ID: 16479856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging modalities in head-and-neck cancer patients.
    Sham ME; Nishat S
    Indian J Dent Res; 2012; 23(6):819-21. PubMed ID: 23649071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of pretherapeutic lymph node diagnosis in head and neck tumors. Clinical value of 18-FDG positron emission tomography (PET)].
    Di Martino E; Nowak B; Krombach GA; Sellhaus B; Hausmann R; Cremerius U; Büll U; Westhofen M
    Laryngorhinootologie; 2000 Apr; 79(4):201-6. PubMed ID: 10838683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPECT-CT for topographic mapping of sentinel lymph nodes prior to gamma probe-guided biopsy in head and neck squamous cell carcinoma.
    Wagner A; Schicho K; Glaser C; Zettinig G; Yerit K; Lang S; Klug C; Leitha T
    J Craniomaxillofac Surg; 2004 Dec; 32(6):343-9. PubMed ID: 15555515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of positron emission tomography in the management of head and neck cancer in the molecular therapy era.
    Garcia C; Flamen P
    Curr Opin Oncol; 2008 May; 20(3):275-9. PubMed ID: 18391626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in imaging in the work-up of head and neck cancer patients.
    de Bree R; Castelijns JA; Hoekstra OS; Leemans CR
    Oral Oncol; 2009 Nov; 45(11):930-5. PubMed ID: 19692289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and therapeutic imaging for cancer: therapeutic considerations and future directions.
    Roach M; Alberini JL; Pecking AP; Testori A; Verrecchia F; Soteldo J; Ganswindt U; Joyal JL; Babich JW; Witte RS; Unger E; Gottlieb R
    J Surg Oncol; 2011 May; 103(6):587-601. PubMed ID: 21480253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging in head and neck oncology.
    Alberico RA; Husain SH; Sirotkin I
    Surg Oncol Clin N Am; 2004 Jan; 13(1):13-35. PubMed ID: 15062359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of diagnostic imaging in melanoma.
    Dancey AL; Mahon BS; Rayatt SS
    J Plast Reconstr Aesthet Surg; 2008 Nov; 61(11):1275-83. PubMed ID: 18694659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging in cutaneous melanoma.
    Ho Shon IA; Chung DK; Saw RP; Thompson JF
    Nucl Med Commun; 2008 Oct; 29(10):847-76. PubMed ID: 18769303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of lymphoscintigraphy and PET in the management of head and neck melanoma.
    Kokoska MS; Olson G; Kelemen PR; Fosko S; Dunphy F; Lowe VJ; Stack BC
    Otolaryngol Head Neck Surg; 2001 Sep; 125(3):213-20. PubMed ID: 11555756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI.
    Nowak B; Di Martino E; Jänicke S; Cremerius U; Adam G; Zimny M; Reinartz P; Büll U
    Nuklearmedizin; 1999; 38(8):312-8. PubMed ID: 10615664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node biopsy: A new perspective in head and neck mucosal melanoma?
    Stárek I; Koranda P; Benes P
    Melanoma Res; 2006 Oct; 16(5):423-7. PubMed ID: 17013091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods.
    Kresnik E; Mikosch P; Gallowitsch HJ; Kogler D; Wiesser S; Heinisch M; Unterweger O; Raunik W; Kumnig G; Gomez I; Grünbacher G; Lind P
    Eur J Nucl Med; 2001 Jul; 28(7):816-21. PubMed ID: 11504077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging modalities in pediatric oncology.
    States LJ; Meyer JS
    Radiol Clin North Am; 2011 Jul; 49(4):579-88, v. PubMed ID: 21807163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
    Kitagawa Y; Nishizawa S; Sano K; Ogasawara T; Nakamura M; Sadato N; Yoshida M; Yonekura Y
    J Nucl Med; 2003 Feb; 44(2):198-206. PubMed ID: 12571209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral cavity squamous cell carcinoma: role of pretreatment imaging and its influence on management.
    Arya S; Rane P; Deshmukh A
    Clin Radiol; 2014 Sep; 69(9):916-30. PubMed ID: 24908285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Imaging in head and neck cancers].
    Iannessi A; Ouvrier MJ; Thariat J; Marcy PY
    Bull Cancer; 2014 May; 101(5):469-80. PubMed ID: 24886898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear medicine in oral and maxillofacial diagnosis: a review for the practicing dental professional.
    Baur DA; Heston TF; Helman JI
    J Contemp Dent Pract; 2004 Feb; 5(1):94-104. PubMed ID: 14973563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site.
    Cianchetti M; Mancuso AA; Amdur RJ; Werning JW; Kirwan J; Morris CG; Mendenhall WM
    Laryngoscope; 2009 Dec; 119(12):2348-54. PubMed ID: 19718744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.